Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coalition-I: Hydroxychloroquine and Azithromycin for COVID-19
NCT04322123Phase 3Completed
- Sponsor
- HCor
- Start
- Apr 2020
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by HCor. Primary endpoint: Clinical status on a 7-level ordinal scale at 15 days. Started Apr 2020; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04322123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04322123.